05/15/2024
6:39 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
6:14 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
6:34 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
4:15 PM | Adaptimmune Therapeutics (Filer)
| Form ARS | |
04/12/2024
7:05 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
7:00 AM | Adaptimmune Therapeutics (Filer)
| Form DEF 14A | |
04/02/2024
7:38 PM | Adaptimmune Therapeutics (Subject)
New Enterprise Associates 14, L.P. (Filed by)
| Form SC 13D/A | |
|
04/01/2024
7:01 AM | Adaptimmune Therapeutics (Filer)
| Form PRE 14A | |
03/26/2024
10:59 AM | Adaptimmune Therapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
03/26/2024
11:00 AM | Adaptimmune Therapeutics (Issuer)
EcoR1 Capital, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/06/2024
6:05 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
6:12 AM | Adaptimmune Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2024
7:13 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
4:07 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
4:26 PM | Adaptimmune Therapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G | |
01/29/2024
10:52 AM | Adaptimmune Therapeutics (Subject)
BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
01/17/2024
4:30 PM | Adaptimmune Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:30 PM | Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
Bertrand William C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:30 PM | Adaptimmune Therapeutics (Issuer)
Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:31 PM | Adaptimmune Therapeutics (Issuer)
Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:31 PM | Adaptimmune Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:31 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:00 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:01 PM | Adaptimmune Therapeutics (Issuer)
Norry Elliot (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:01 PM | Adaptimmune Therapeutics (Issuer)
Wood Gavin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:01 PM | Adaptimmune Therapeutics (Issuer)
TAYTON-MARTIN HELEN KATRINA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:02 PM | Adaptimmune Therapeutics (Issuer)
Brewer Joanna Elizabeth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:02 PM | Adaptimmune Therapeutics (Issuer)
Lunger John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:03 PM | Adaptimmune Therapeutics (Issuer)
Hege Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:03 PM | Adaptimmune Therapeutics (Issuer)
Bertrand William C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:06 PM | Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:46 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
6:13 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
11:59 AM | Adaptimmune Therapeutics (Subject)
Long Focus Capital Management, LLC (Filed by)
| Form SC 13G | |
11/08/2023
6:37 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
7:07 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
6:00 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2023
4:19 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
6:42 AM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
4:01 PM | Adaptimmune Therapeutics (Issuer)
Menzel Garry E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
3:15 PM | Adaptimmune Therapeutics (Subject)
Matrix Capital Management Company, LP (Filed by)
| Form SC 13G/A | |
This military-backed stock “owns” AI market (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
07/03/2023
4:16 PM | Adaptimmune Therapeutics (Issuer)
Behbahani Ali (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:00 PM | Adaptimmune Therapeutics (Issuer)
Allen Andrew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:01 PM | Adaptimmune Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:02 PM | Adaptimmune Therapeutics (Issuer)
Alleva Lawrence M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:02 PM | Adaptimmune Therapeutics (Issuer)
Sigal Charles Elliott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:03 PM | Adaptimmune Therapeutics (Issuer)
Menzel Garry E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:04 PM | Adaptimmune Therapeutics (Issuer)
Furey John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
4:04 PM | Adaptimmune Therapeutics (Issuer)
Hegde Priti (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
3:48 PM | Adaptimmune Therapeutics (Filer)
| Form S-8 POS | |
06/29/2023
3:54 PM | Adaptimmune Therapeutics (Filer)
| Form S-8 POS | |
06/29/2023
3:25 PM | Adaptimmune Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
8:15 PM | Adaptimmune Therapeutics (Issuer)
Rawcliffe Adrian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
